A Phase 2b, comparative, two arm randomized, placebo-controlled, double blinded multi-centric study to Evaluate the Safety, Tolerability, and Efficacy of Oral Insulin 16 mg /day or placebo in subjects with Type 2 Diabetes Mellitus (DM) who are currently on diet alone or diet with monotherapy - Metformin up to 2.5 g/day

Trial Profile

A Phase 2b, comparative, two arm randomized, placebo-controlled, double blinded multi-centric study to Evaluate the Safety, Tolerability, and Efficacy of Oral Insulin 16 mg /day or placebo in subjects with Type 2 Diabetes Mellitus (DM) who are currently on diet alone or diet with monotherapy - Metformin up to 2.5 g/day

Completed
Phase of Trial: Phase II

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Insulin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Most Recent Events

    • 07 Sep 2011 Planned initiation date changed to 1 Jan 2009.
    • 16 Sep 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top